Trial · NCT01390948
Adverse events411
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 411
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Chemoradiation + TMZ | 6 | 56 | 13 |
| other | ANAEMIA | Blood and lymphatic system disorders | Chemoradiation + Bevacizumab + TMZ | 5 | 60 | 9 |
| other | ANAEMIA | Blood and lymphatic system disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Chemoradiation + TMZ | 6 | 56 | 11 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Chemoradiation + Bevacizumab + TMZ | 3 | 60 | 3 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Chemoradiation + TMZ | 3 | 56 | 4 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Chemoradiation + Bevacizumab + TMZ | 0 | 60 | 0 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Chemoradiation + TMZ | 12 | 56 | 26 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Chemoradiation + Bevacizumab + TMZ | 9 | 60 | 19 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Chemoradiation + TMZ | 8 | 56 | 20 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Chemoradiation + Bevacizumab + TMZ | 10 | 60 | 31 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | EAR PAIN | Ear and labyrinth disorders | Chemoradiation + TMZ | 2 | 56 | 2 |
| other | EAR PAIN | Ear and labyrinth disorders | Chemoradiation + Bevacizumab + TMZ | 3 | 60 | 3 |
| other | EAR PAIN | Ear and labyrinth disorders | Bevacizumab + TMZ Young Patient Cohort (YPC) | 0 | 3 | 0 |
| other | EYE PAIN | Eye disorders | Chemoradiation + TMZ | 4 | 56 | 4 |
| other | EYE PAIN | Eye disorders | Chemoradiation + Bevacizumab + TMZ | 1 | 60 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01390948/events